Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Efficacy and treatment satisfaction of Technosphere Insulin System reported by patients

Jan. 28, 2010

Acrux submits NDA to FDA for Axiron in hypogonadism

Jan. 28, 2010

JCR and Dainippon Sumitomo to terminate comarketing agreement for Growject

Jan. 28, 2010

Dainippon Sumitomo's Metgluco granted Japanese manufacturing and marketing approval

Jan. 28, 2010

FDA reschedules review of NDA for Theratechnologies' tesamorelin

Jan. 27, 2010

FDA approves Novo Nordisk's Victoza for certain adults with type 2 diabetes

Jan. 27, 2010

Novel modulator of mitochondrial membrane potential shows antidiabetic effects in mice

Jan. 27, 2010

Romiplostim appears to be safe in MDS patients with thrombocytopenia

Jan. 27, 2010

EMEA initiates review of Amsterdam MolecularTherapeutics' MAA for Glybera in LPLD

Jan. 27, 2010

Transition Therapeutics reports results from phase II trial of TT-223 in type 2 diabetes

Jan. 26, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...